RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
RT @drahmetrasim: Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kaza…
Tabii bağışıklık gibisi yok! 12541 sağlık çalışanının 31 hafta takip edildikleri araştırmaya göre KOVİD geçirilerek kazanılan tabii bağışıklık semptomatik hastalığı yüzde 100 önledi, sadece 2 kişide asemptomatik re-enfeksiyon görüldü. https://t.co/iDvF2vT
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @lord_juli: Recordemos, DOS casos ASINTOMÁTICOS de reinfección tras infección natural obtenidos del seguimiento de >12500 casos en sanit…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @lord_juli: Recordemos, DOS casos ASINTOMÁTICOS de reinfección tras infección natural obtenidos del seguimiento de >12500 casos en sanit…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
Natural immunisation held up well over the 6 months of the study, with only two cases of asymptomatic reinfections observed. https://t.co/oNm3rH1QJU
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
Recordemos, DOS casos ASINTOMÁTICOS de reinfección tras infección natural obtenidos del seguimiento de >12500 casos en sanitarios. Periodo de estudio 6 meses, ahora serán nueve. Natural immunity esisten.
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
come riportato più sopra, i waccini sono efficaci forse al 95% forse solo al 19%. L'immunità naturale acquisita dopo la malattia invece è efficace al 99.99% come dice questo studio su 12000+ sanitari https://t.co/xA0oXsvZox https://t.co/zL9okAdkH8
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
Your government continues to ignore natural immunity as a factor
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @gerdosi: New mRNA vaccine technologies may offer 94-95 % efficacy. What an achievement of 21st century science! On the other hand, good…
RT @BallouxFrancois: New study following 12,541 healthcare workers for #COVID19 re-infection over 31 weeks published in NEJM. Natural immun…